Y. Sato

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

G. Sobue, K. Hirata, K. Kaida, 2018, The Lancet Neurology.

Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study

C. Nakaseko, H. Hanaoka, K. Shibuya, 2015, BMJ Open.

TRH stimulation test in healthy elderly: paradoxical response of growth hormone is abnormal in normal aging.

Y. Sato, S. Ohbu, H. Fukuda, 1995, Internal medicine.

Regional differences in homicide patterns in five areas of Japan.

Y. Sakairi, K. Gonmori, Y. Sato, 2001, Legal medicine.